benzimidazole has been researched along with Multiple Myeloma in 1 studies
1H-benzimidazole : The 1H-tautomer of benzimidazole.
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, T | 1 |
| Li, MH | 1 |
| Liu, J | 1 |
| Huang, N | 1 |
| Li, N | 1 |
| Liu, SN | 1 |
| Liu, Y | 1 |
| Zhang, T | 1 |
| Zou, Q | 1 |
| Li, H | 1 |
1 other study available for benzimidazole and Multiple Myeloma
| Article | Year |
|---|---|
Benzimidazole derivative, BMT-1, induces apoptosis in multiple myeloma cells via a mitochondrial-mediated pathway involving H+/K+-ATPase inhibition.
Topics: Apoptosis; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; H(+)-K(+)-Exchanging ATPase; Humans | 2014 |